Premium
Puberty Menorrhagia Due to Bernard Soulier Syndrome and its Successful Treatment by ‘OvraP Hormonal Tablets
Author(s) -
SharmaJ J. B.,
Buckshee K.,
Sharma S.
Publication year - 1991
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/j.1479-828x.1991.tb02825.x
Subject(s) - medicine , pill , progestogen , family planning , antifibrinolytic , levonorgestrel , bernard–soulier syndrome , menstruation , clinical research , tranexamic acid , gynecology , obstetrics , hormone , population , surgery , research methodology , blood loss , pharmacology , platelet , environmental health
EDITORIAL COMMENT: Prostaglandin synthetase inhibitors, antifibrinolytic agents, oral contraceptives and the release of progestogen from a levonorgestrel‐releasing intrauterine contraceptive device (IUD) have all been shown to be effective in the treatment of idiopathic menorrhagia; a recent study found the progestogen‐releasing IUD to be the most effective of these methods 1 We accepted this case report to inform readers that severe anaemia from pubertal menorrhagia due to a haemorrhagic disorder can be successfully treated with oral contraceptive tablets. This is a message to be remembered for the rare patient with life‐threatening menorrhagia and a coagulation disorder whose general medical condition may preclude surgery ‐ the simple contraceptive pill may control the problem.